Spinal cord lesion: Assessment and treatment of neurogenic bladder: Review

被引:0
作者
Zinnuroglu, Murat [1 ]
机构
[1] Gazi Univ, Tip Fak, Fizik Tip Rehabil AD, Ankara, Turkey
来源
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI | 2007年 / 27卷 / 02期
关键词
spinal cord diseases; spinal cord injuries; urinary bladder; neurogenic; urinary incontinence; SELECTIVE RECEPTOR ANTAGONIST; DETRUSOR OVERACTIVITY; PROPIVERINE HYDROCHLORIDE; DARIFENACIN; COMBINATION; DYSFUNCTION; MANAGEMENT; MYOPLASTY; CHILDREN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurogenic bladder and its complications were the main causes of mortality and morbidity among patients with spinal cord lesions in the past. Recently, major advances in medical management have markedly prolonged survival and improved quality of life for patients with spinal cord injury. However, assessment and treatment of the urinary system in such patients includes different and indispensable components compared to a typical patient with lower urinary tract symptoms. Therefore, a very careful assessment including detailed neurourologic examination and a well-planned management and follow-up strategy is necessary for patients with neurogenic bladder due to spinal cord lesions.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 26 条
[1]   The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society [J].
Abrams, P ;
Cardozo, L ;
Fall, M ;
Griffiths, D ;
Rosier, P ;
Ulmsten, U ;
van Kerrebroeck, P ;
Victor, A ;
Wein, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (01) :116-126
[2]   Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury [J].
Benevento, BT ;
Sipski, ML .
PHYSICAL THERAPY, 2002, 82 (06) :601-612
[3]  
BUMS AS, 2001, SPINE S, V26, P129
[4]   Pharmacotherapy for neurogenic detrusor overactivity [J].
Chancellor, Michael B. ;
Anderson, Rodney U. ;
Boone, Timothy B. .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2006, 85 (06) :536-545
[5]   Darifenacin:: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder [J].
Chapple, CR .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) :1493-1500
[6]  
CORCOS J, 2004, NEUROGENIC BLADDER, P11
[7]  
DRAKE MJ, 2004, NEUROGENIC BLADDER, P17
[8]   Recent advances in the management of the neurogenic bladder [J].
Elliott, DS ;
Boone, TB .
UROLOGY, 2000, 56 (6A) :76-81
[9]   Management of overactive bladder and urge urinary incontinence in the elderly patient [J].
Erdem, N ;
Chu, FM .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 :29-36
[10]   Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity -: A retrospective study [J].
Grigoleit, Ute ;
Muertz, Gerd ;
Laschke, Sebastian ;
Schuldt, Matthias ;
Goepel, Mark ;
Kramer, Guus ;
Stoehrer, Manfred .
EUROPEAN UROLOGY, 2006, 49 (06) :1114-1121